Jiangsu Aidea Pharmaceutical Co.,Ltd.

About Jiangsu Aidea Pharmaceutical Co.,Ltd.

Company Profile

Jiangsu Aidea Pharmaceutical Co., Ltd. ("Aidea Pharma", 688488.SH) was established in 2009 and listed on the Shanghai Stock Exchange STAR Market in 2020. As a high-tech pharmaceutical company, Aidea Pharma focuses on developing and marketing comprehensive anti-HIV/AIDS product portfolios while leveraging its competitive advantages in the research and production of human urine-derived proteins.

  • CN
  • 2022
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (innovator finished products)
Contact info

Products from Jiangsu Aidea Pharmaceutical Co.,Ltd. (7)

  • Ainuovirine Tablets

    Product Ainuovirine Tablets

    The first innovative Class I anti-HIV/AIDS tablets approved for marketing in China. A new generation of non-nucleoside reverse transcriptase inhibitors (NNRTIs).
  • Ulinastatin

    Product Ulinastatin

    1、A natural broad-spectrum proteinase inhibitor extracted from human urine

    2、Block the process of SIRS and MODS

    2、Protect the function of vital organs

  • Urokinase

    Product Urokinase

    1、A kind of zymoprotein extracted from human urine

    2、Activate the endogenous fibrinolysis system and convert plasminogen into plasmin

    3、Favorable ...

  • Sennae Folium Granule

    Product Sennae Folium Granule

    1、A natural botanical drug for the treatment of constipation recommended by the WGO* Guideline

    2、Purge heat, activate stagnation and relax Intestines

    3、An exclusive product with double sales channels of OTC & prescription

     

    *WGO: World Gas...
  • Ainuomiti Tablets (Anti-HIV/AIDS innovative drug)

    Product Ainuomiti Tablets (Anti-HIV/AIDS innovative drug)

    Ainuomiti Tablets 

    (Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets)

     

    The first innovative oral anti-HIV/AIDS single-tablet combination in China, containing key NCE of Ainuovirine. 

  • Ainuovirine Tablets (Anti-HIV/AIDS innovative drug)

    Product Ainuovirine Tablets (Anti-HIV/AIDS innovative drug)

    Ainuovirine Tablets

     

    The first innovative Class I anti-HIV/AIDS tablets approved for marketing in China. A new generation of non-nucleoside reverse transcriptase inhibitors (NNRTIs).

  • Bacillus Cereus Tablets

    Product Bacillus Cereus Tablets

    1、A kind of symbiotic preparation containing unique probiotic (DM423)

    2、Quickly eliminate abdominal distention

    3、Significantly improve the symptoms of acute diarrhea

    4、Restore intestinal flora with two-way coordinating

    5、Freely used in combination with antibiotic...

Jiangsu Aidea Pharmaceutical Co.,Ltd. Resources (1)